FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2025/10/095852 [Registered on: 09/10/2025] Trial Registered Prospectively
Last Modified On: 07/10/2025
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Drug
Surgical/Anesthesia 
Study Design  Randomized, Parallel Group, Active Controlled Trial 
Public Title of Study   What’s the Best Way to Use Lignocaine for Safer Tube Insertion During Surgery? A Comparison of Three Methods 
Scientific Title of Study   Comparing The Hemodynamic Effects Of Ultrasound Guided Transtracheal Lignocaine, Intravenous Lignocaine, Nebulized Lignocaine During Endotracheal Intubation – A Randomized Controlled Trial 
Trial Acronym  nil 
Secondary IDs if Any  
Secondary ID  Identifier 
Nil  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Dr Prasanna Vadhanan 
Designation  HOD 
Affiliation  Vinayaka Missions Medical College and Hospital 
Address  Room No 1,Department of Anesthesia,Vinayaka Missions Medical College and Hospital,keezhakasakudimedu,Kottucherry Post,Karaikal,Puducherry.

Karaikal
PONDICHERRY
609609
India 
Phone  9486489690  
Fax    
Email  vadhanan.prasanna@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr Stephen Anto S 
Designation  Junior Resident/ Post Graduate 
Affiliation  Vinayaka Missions Medical College and Hospital 
Address  Room No 1,Department of Anesthesia,Vinayaka Missions Medical College and Hospital,keezhakasakudimedu,kottucherry Post,Karaikal,Puducherry.

Karaikal
PONDICHERRY
609609
India 
Phone  8248629177  
Fax    
Email  stephenantosuresh@gmail.com  
 
Details of Contact Person
Public Query
 
Name  Dr Stephen Anto S 
Designation  Junior Resident/ Post Graduate 
Affiliation  Vinayaka Missions Medical College and Hospital 
Address  Room No 1,Department of Anesthesia,Vinayaka Missions Medical College and Hospital,keezhakasakudimedu,kottucherry Post,Karaikal,Puducherry.


PONDICHERRY
609609
India 
Phone  8248629177  
Fax    
Email  stephenantosuresh@gmail.com  
 
Source of Monetary or Material Support  
NIL 
 
Primary Sponsor  
Name  Vinayak Missions Medical College and Hospital 
Address  Department of Anesthesia,Vinayaka Missions Medical College and Hospital,Keezhakasakudimedu Post,Karaikal,Puducherry 
Type of Sponsor  Private medical college 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Stephen Anto S  Vinayaka Missions Medical College and Hospital  Department of Anesthesia,Vinayaka Missions Medical College and Hospital,keezhakasakudimedu,Kottucherry Post,Karaikal,Puducherry
Karaikal
PONDICHERRY 
8248629177

stephenantosuresh@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Institutional Ethics Committee  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition: O||Medical and Surgical,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Intervention  Group A(Transtracheal Lignocaine)  Patients will receive ultrasound-guided transtracheal lignocaine (2 ml of 4 percentage of lignocaine) 3 minutes before intubation. 
Comparator Agent  Group B(Intravenous Lignocaine)  Patients will receive 2 percentage of intravenous lignocaine (1.5 mg per kg) 3 minutes before intubation 
Comparator Agent  Group C(Nebulized Lignocaine)  Patients will receive 2 ml of 4 percentage of lignocaine nebulized 10 minutes before intubation. 
 
Inclusion Criteria  
Age From  18.00 Year(s)
Age To  60.00 Year(s)
Gender  Both 
Details  1. ASA physical status 1,2 and 3
2. Patients scheduled for elective surgery under general anesthesia requiring endotracheal intubation
3. Modified Mallampati Class 1 or 2
 
 
ExclusionCriteria 
Details  1. ASA physical status 3 or higher
2. Obese patients (BMI greater than 30)
3. Emergency surgery
4. Age less than 18 years or more than 60 years
5. Modified Mallampati Class 3 or 4
6. Known allergy to lignocaine
7. Patients with anticipated difficult airway
8. Duration of laryngoscopy exceeding 15 seconds
9. Anatomical abnormalities of the neck or anterior cervical region
10. Inability to identify the cricothyroid membrane on ultrasound
 
 
Method of Generating Random Sequence   Computer generated randomization 
Method of Concealment   Case Record Numbers 
Blinding/Masking   Participant and Outcome Assessor Blinded 
Primary Outcome  
Outcome  TimePoints 
1. To evaluate and compare the effects on hemodynamic response associated with laryngoscopy and intubation in these three groups.
2. To assess the incidence of tachycardia or hypertension during and immediately after intubation as a measure of sympathetic stress response.
 

1. Baseline (before induction)
2. After induction (before administration of study drug)
3. At intubation (0 minute)
4. 1, 3, 5 minutes after intubation
 
 
Secondary Outcome  
Outcome  TimePoints 
NIL  NIL 
 
Target Sample Size   Total Sample Size="120"
Sample Size from India="120" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   Phase 2/ Phase 3 
Date of First Enrollment (India)   22/10/2025 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="1"
Months="6"
Days="0" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary  

This randomized controlled trial evaluates and compares the hemodynamic responses (heart rate, blood pressure changes) during endotracheal intubation when lignocaine is administered through three different routes: ultrasound-guided transtracheal injection, intravenous infusion, and nebulization.

Ninety adult patients (ASA I–II), scheduled for elective surgeries requiring general anesthesia with intubation, will be randomly assigned to one of the three groups. Each group will receive a standardized dose of lignocaine through one of the routes before intubation. Hemodynamic parameters will be recorded at baseline, during laryngoscopy, and at intervals after intubation.

The primary objective is to determine which route provides the most stable cardiovascular response during intubation.
Secondary objectives include assessing patient comfort, ease of administration, and incidence of adverse effects.

The study aims to guide anesthesiologists in selecting the optimal method of lignocaine administration to minimize the stress response and enhance patient safety during airway management.

 
Close